SMTL ID : 6nec.1 (1 other biounit)

STRUCTURE OF RET PROTEIN TYROSINE KINASE DOMAIN IN COMPLEX WITH NINTEDANIB

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.87 Å

Oligo State

monomer

Ligands

1 x XIN: methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate(Non-covalent)

XIN.1: 20 residues within 4Å: Chain A: T.30, L.31, G.32, V.39, A.57, K.59, E.76, L.80, I.89, V.105, E.106, Y.107, A.108, K.109, Y.110, G.111, S.112, L.182, S.192, D.193 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:V.39, A:V.39, A:V.105, A:Y.107, A:L.182, A:L.182 Hydrogen bonds: A:E.106, A:A.108, A:A.108, A:D.193 Water bridges: A:K.29 Salt bridges: A:K.59

1 x FMT: FORMIC ACID(Non-functional Binders)

FMT.2: 6 residues within 4Å: Chain A: R.174, L.196, R.198, K.208, G.212, R.213 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.174, A:R.174, A:R.198, A:K.208, A:R.213

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Terzyan, S.S. et al., Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. J.Biol.Chem. (2019)

Release Date

2019-06-05

Peptides

Proto-oncogene tyrosine-protein kinase receptor Ret: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Proto-oncogene tyrosine-protein kinase receptor Ret

Related Entries With Identical Sequence